We speculated that a higher rate of mutations may occur in patients with high expression of SAMHD1 resulting in disease progression because mutations in SAMHD1 that alter its dNTPase activity are associated with colon cancer (40). Here, SAMHD1 is linked to malignant colon neoplasm.